The ARPC5L Knockout HT29 Polyclonal Cells product consists of a heterogeneous population of HT29 human colorectal adenocarcinoma cells that have undergone CRISPR/Cas9-mediated disruption of the ARPC5L gene. This polyclonal knockout pool allows researchers to study the collective loss-of-function effects of ARPC5L in a mixed genetic background, avoiding clonal selection biases. The cells are provided as a ready-to-use population for experiments aimed at interrogating the role of ARPC5L, a subunit of the actin-related protein 2/3 (Arp2/3) complex, in cellular processes dependent on branched actin filament nucleation.
The HT29 parental cell line is a widely utilized model of human colorectal adenocarcinoma, originally isolated from a 44-year-old female patient. These cells exhibit an epithelial morphology and grow as adherent monolayers, retaining characteristic features of intestinal epithelial cells. HT29 cells harbor mutations in APC and TP53, but they express wild-type KRAS and BRAF, making them a versatile platform for studying signaling pathways relevant to colorectal cancer. Their well-documented migratory and invasive properties render them particularly suitable for investigating genes involved in actin cytoskeleton dynamics and metastasis.
ARPC5L encodes an accessory subunit of the Arp2/3 complex, which functions as the principal nucleator of branched actin networks. This complex is activated by nucleation-promoting factors (NPFs) such as WAVE and N-WASP, themselves controlled by Rho GTPases Rac1 and CDC42. Upon activation, the Arp2/3 complex binds to existing actin filaments and initiates a new branch, driving lamellipodial protrusion, cell migration, and endocytosis. ARPC5L directly interacts with core Arp2/3 subunits (ARP2, ARP3, ARPC1?C5) and regulatory proteins like cortactin to stabilize actin branches. Upstream, EGFR signaling and Rac1 converge on the WAVE regulatory complex, linking extracellular cues to cytoskeletal remodeling. Disruption of ARPC5L is thus predicted to impair actin polymerization and downstream processes such as invadopodia formation and cell invasion.
Given the central role of the Arp2/3 complex in actin-driven cell motility, ARPC5L knockout in HT29 cells provides a relevant model for dissecting the contribution of branched actin assembly to colorectal cancer progression. HT29 cells are known to exhibit relatively high basal migration and invasion potential, and ablation of ARPC5L is expected to attenuate these properties. This knockout model may reveal dependencies on Arp2/3-mediated actin nucleation for tumor cell dissemination, particularly in the context of Rho GTPase signaling and WNT pathway cross-talk. Additionally, the polyclonal nature of the knockout pool allows the observation of phenotypes in a genomically diverse population, which may better reflect the heterogeneity of tumor cells in vivo.
This product is ideally suited for a variety of experimental approaches aimed at elucidating the molecular mechanisms of actin cytoskeleton reorganization in colorectal cancer. Researchers can employ immunofluorescence staining with phalloidin to visualize F-actin architecture, Western blotting to confirm ARPC5L protein depletion, and RT-qPCR to assess gene expression changes. Functional assays such as wound healing and Transwell invasion assays enable quantitative assessment of cell migration and invasiveness. Furthermore, the cells can be utilized in high-throughput compound screens targeting migration inhibitory pathways or to validate the role of specific Rho GTPase effectors. For additional technical support or to inquire about custom cell engineering services, please contact Ascent Research.
